US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.12

-0.0700-5.88%

Volume:138.32K

Turnover:156.86K

Market Cap:158.38M

PE:5.23

High:1.15

Open:1.15

Low:1.11

Close:1.19

52wk High:27.36

52wk Low:1.11

Shares:141.41M

Float Shares:36.77M

Volume Ratio:2.76

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-5.8037

ROE:-871.42%

ROA:-49.99%

PB:-8.33

PE(LYR):-0.19

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Veraxa Biotech Director Warren Hosseinion Acquires 6,024 Common Shares Worth $10,060.08

VERAXA Biotech (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase

VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.12,"timestamp":1790964467149,"preClose":1.19,"halted":0,"volume":138324,"delay":0,"changeRate":-0.05882352941176457,"floatShares":36767500,"shares":141407813,"eps":0.2142,"marketStatus":"Trading","change":-0.07,"latestTime":"10-02 14:14:45 EDT","open":1.15,"high":1.15,"low":1.105,"amount":156864.5478204,"amplitude":0.037815,"askPrice":1.13,"askSize":732,"bidPrice":1.12,"bidSize":3036,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.19,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.19,"latestTime":"09:25 EDT","volume":6063,"amount":7152.1809657,"timestamp":1790947525081,"change":-0.01,"changeRate":-0.008403,"amplitude":0.084034},"postHourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.19,"latestTime":"18:55 EDT","volume":823,"amount":995.666,"timestamp":1790895345809,"change":0.02,"changeRate":0.016807,"amplitude":0.016807},"volumeRatio":2.763598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":36767500,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":2.763598,"shares":141407813,"dividePrice":0,"high":1.15,"amplitude":0.037815,"preClose":1.19,"low":1.105,"week52Low":1.105,"pbRate":"-8.33","psRate":"5603.79","week52High":27.36,"institutionHeld":0,"latestPrice":1.12,"committee":0.611465,"eps":0.2142,"divideRate":0,"volume":138324,"delay":0,"ttmEps":0.2142,"open":1.15,"prevYearClose":18.65,"prevWeekClose":1.41,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":1.41,"twentyDayClose":1.53,"sixtyDayClose":2.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-10-01","current":5.228758,"percent":0.655172,"low":-3.022108,"twenty":-2.662061,"median":-2.458069,"eighty":-1.274725,"high":-0.413162,"avg":-2.061784,"sd":0.795915,"marketCap":176759766},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-11","current":-2.842124,"twenty":-2.738773,"median":-1.34261,"eighty":-1.03732,"marketCap":233322891},{"date":"2026-09-18","current":-2.57236,"twenty":-2.751957,"median":-2.365287,"eighty":-1.181392,"marketCap":207869485},{"date":"2026-09-25","current":-2.481882,"twenty":-2.738773,"median":-2.472656,"eighty":-1.249249,"marketCap":199385016},{"date":"2026-10-01","current":-2.204044,"twenty":-2.662061,"median":-2.458069,"eighty":-1.274725,"marketCap":176759766}],"updateTime":1790964885031},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671422472","title":"Veraxa Biotech Director Warren Hosseinion Acquires 6,024 Common Shares Worth $10,060.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2671422472","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671422472?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:13","pubTimestamp":1790712788,"startTime":"0","endTime":"0","summary":"Veraxa Biotech director Warren Hosseinion acquires 6,024 common shares worth $10,060.08Veraxa Biotech director Warren Hosseinion reported buying 6,024 ordinary shares at USD 1.67.Stake rose to 634,692","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLb5hrhn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veraxa Biotech Director Warren Hosseinion Acquires 6,024 Common Shares Worth $10,060.08","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123738","title":"VERAXA Biotech (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123738?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:30","pubTimestamp":1790091024,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 22nd, 2026, FinanceWire VERAXA is advancing an oncology pipeline centered on its proprietary BiTAC(R) platf...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-builds-oncology-pipeline-around-bitac-platform-public-market-story-enters-next-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-builds-oncology-pipeline-around-bitac-platform-public-market-story-enters-next-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SQQQ","BK4581","MNQmain","QQQJ","TECS","QQQ","FTEC","GPIQ","QLD","NQmain","QQQY","TQQQ","NDX","R","QQQE","QDTE","NVIW.SI","03086","BK4232","BK4588","QQQM","JEPQ","TQQY","IYW","VRXA","BK4022","XBI",".IXIC","BK4585","PSQ","QID","BK4139","ONEQ","QYLG","QQQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492097","title":"VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492097","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492097?lang=en_us&edition=fundamental","pubTime":"2026-09-19 02:31","pubTimestamp":1789756268,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 18th, 2026, FinanceWire VERAXA has appointed Raju Willener as Chief Financial Officer, effective immediatel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-adds-capital-markets-veteran-as-cfo-while-advancing-bitac-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-adds-capital-markets-veteran-as-cfo-while-advancing-bitac-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","NVIW.SI","ONEQ","QQQY","TQQY","NDX",".IXIC","QQQJ","TECS","XBI","BK4139","QQQA","03086","GPIQ","TQQQ","QID","BK4581","FTEC","PSQ","SQQQ","VRXA","QQQE","QQQM","QDTE","MNQmain","JEPQ","QYLG","QLD","QQQ","BK4588","IYW","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987897","title":"VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987897?lang=en_us&edition=fundamental","pubTime":"2026-09-17 00:30","pubTimestamp":1789576207,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 16th, 2026, FinanceWire VERAXA is developing antibody-based cancer therapies aimed at improving the therape...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-building-a-new-approach-to-precision-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-building-a-new-approach-to-precision-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","QID","QQQJ","QQQ","ONEQ","GPIQ","TQQQ","XBI","TECS",".IXIC","BK4581","BK4139","QQQY","QQQM","VRXA","BK4585","QLD","IYW","NQmain","TQQY","JEPQ","FTEC","03086","PSQ","QYLG","MNQmain","QDTE","QQQA","SQQQ","NVIW.SI","QQQE","NDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":19,"pageCount":1,"totalSize":76,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}